Literature DB >> 3027177

Identification of an interferon-gamma response region 5' of the human histocompatibility leukocyte antigen DR alpha chain gene which is active in human glioblastoma multiforme lines.

P V Basta, P A Sherman, J P Ting.   

Abstract

The expression of class II major histocompatibility (MHC) antigens is central to the mounting of a successful immune response. Understanding the molecular mechanisms involved in the induction of class II MHC expression may therefore provide the knowledge necessary to manipulate the immune system appropriately. We are particularly interested in the induction of class II MHC antigens on cells in the brain, because of the potential involvement of such brain cells in the initiation and perpetuation of autoimmune-like diseases of the central nervous system. We examined the mechanisms involved in interferon-gamma (IFN-gamma) induction of class II MHC antigens on a human glioblastoma multiforme cell line. This paper describes the identification of a 297-bp (base pair) fragment of the class II MHC DR alpha chain gene which is involved in IFN-gamma induction. We were able to identify this IFN-gamma responsive sequence by preparing recombinant plasmids containing 5' flanking pieces of the human DR alpha chain gene placed upstream of the indicator gene, chloramphenicol acetyltransferase (CAT). These recombinant plasmids were transfected into human glioma cells which were then cultured in the presence or absence of IFN-gamma. After 48 hr, transient expression of CAT was assayed by thin layer chromatography. CAT enzyme activity was significantly increased only in IFN-gamma-treated cells. This increase was also reflected at the RNA level in that IFN-gamma treatment resulted in higher CAT transcripts. A computer homology search revealed a possible consensus sequence shared among different IFN-gamma-inducible genes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027177

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor.

Authors:  K M Haan; W W Kwok; R Longnecker; P Speck
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  X-box-binding proteins positively and negatively regulate transcription of the HLA-DRA gene through interaction with discrete upstream W and V elements.

Authors:  J P Cogswell; P V Basta; J P Ting
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 3.  Transcriptional regulation of HLA class-II genes.

Authors:  B M Peterlin; G Andersson; E Lötscher; S Tsang
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

4.  The X boxes from promoters of HLA class II B genes at different loci do not complete for nuclear protein-specific binding.

Authors:  E Turco; B J Manfras; L Ge; W A Rudert; M Trucco
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

5.  Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors.

Authors:  S Y Tsang; M Nakanishi; B M Peterlin
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

6.  CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo.

Authors:  K L Wright; K C Chin; M Linhoff; C Skinner; J A Brown; J M Boss; G R Stark; J P Ting
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

7.  Class II box consensus sequences in the HLA-DR alpha gene: transcriptional function and interaction with nuclear proteins.

Authors:  P A Sherman; P V Basta; T L Moore; A M Brown; J P Ting
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

8.  The octamer motif is a B-lymphocyte-specific regulatory element of the HLA-DR alpha gene promoter.

Authors:  P A Sherman; P V Basta; A Heguy; M K Wloch; R G Roeder; J P Ting
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

Authors:  J A Brown; E M Rogers; J M Boss
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

10.  Physiologic target of the Air-1 trans-activator revealed by stable transfection assay.

Authors:  S Sartoris; A De Lerma Barbaro; T Cestari; G Tridente; R S Accolla
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.